Skip to content
10-Q

Quarterly Report

PETMED EXPRESS INC PETS

0001040130-25-000108

← back to feed
Filed
Dec 19, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Dec 5, 2025 21.37M sh
Shares Diluted Q2 2026 · Sep 30, 2025 20.89M sh
Shares Diluted Q2 2026 · Sep 30, 2025 20.82M sh
Shares Diluted Q2 2026 · Sep 30, 2024 20.94M sh
Shares Diluted Q2 2026 · Sep 30, 2024 20.94M sh
Dividends Paid Q2 2026 · Sep 30, 2025 $23K
Dividends Paid Q2 2026 · Sep 30, 2024 $175K
Capex Q2 2026 · Sep 30, 2025 $3.92M
Capex Q2 2026 · Sep 30, 2024 $1.95M
Operating Cash Flow Q2 2026 · Sep 30, 2025 −$14.45M
Operating Cash Flow Q2 2026 · Sep 30, 2024 −$1.13M
Cash And Equivalents Q2 2026 · Sep 30, 2025 $36.1M
Cash And Equivalents Q2 2026 · Mar 31, 2025 $54.72M
Stockholders Equity Q2 2026 · Sep 30, 2025 $43.06M
Stockholders Equity Q2 2026 · Mar 31, 2025 $85.13M
Current Liabilities Q2 2026 · Sep 30, 2025 $56.68M
Current Liabilities Q2 2026 · Mar 31, 2025 $62.77M
Total Liabilities Q2 2026 · Sep 30, 2025 $57.24M
Total Liabilities Q2 2026 · Mar 31, 2025 $63.57M
Current Assets Q2 2026 · Sep 30, 2025 $59.46M
Current Assets Q2 2026 · Mar 31, 2025 $78.87M
Total Assets Q2 2026 · Sep 30, 2025 $100.3M
Total Assets Q2 2026 · Mar 31, 2025 $148.7M
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.41
Eps Diluted Q2 2026 · Sep 30, 2025 −$2.05
Eps Diluted Q2 2026 · Sep 30, 2024 $0.11
Eps Diluted Q2 2026 · Sep 30, 2024 $0.29
Eps Basic Q2 2026 · Sep 30, 2025 −$0.41
Eps Basic Q2 2026 · Sep 30, 2025 −$2.05
Eps Basic Q2 2026 · Sep 30, 2024 $0.11
Eps Basic Q2 2026 · Sep 30, 2024 $0.30
Sga Expense Q2 2026 · Sep 30, 2025 $14.18M
Sga Expense Q2 2026 · Sep 30, 2025 $27.12M
Sga Expense restated Q2 2026 · Sep 30, 2024 $10.49M
Sga Expense restated Q2 2026 · Sep 30, 2024 $15.37M
Net Income Q2 2026 · Sep 30, 2025 −$8.52M
Net Income Q2 2026 · Sep 30, 2025 −$42.67M
Net Income Q2 2026 · Sep 30, 2024 $2.33M
Net Income Q2 2026 · Sep 30, 2024 $6.08M
Operating Income Q2 2026 · Sep 30, 2025 −$8.38M
Operating Income Q2 2026 · Sep 30, 2025 −$42.51M
Operating Income Q2 2026 · Sep 30, 2024 $554K
Operating Income Q2 2026 · Sep 30, 2024 $4.94M
Gross Profit Q2 2026 · Sep 30, 2025 $12.42M
Gross Profit Q2 2026 · Sep 30, 2025 $26.82M
Gross Profit restated Q2 2026 · Sep 30, 2024 $18.77M
Gross Profit restated Q2 2026 · Sep 30, 2024 $37.81M
Revenue Q2 2026 · Sep 30, 2025 $44.36M
Revenue Q2 2026 · Sep 30, 2025 $95.54M
Revenue restated Q2 2026 · Sep 30, 2024 $58.04M
Revenue restated Q2 2026 · Sep 30, 2024 $124.25M